Events and announcements 

• Addressing stigma: A virtual panel on families and substance use disorder (Prevention First) - October 16 from noon to 1 p.m. 

• Alcohol taxes save lives: Using tax policies to reduce alcohol-related harms (Prevention First) - January 9 from 10 a.m. to 11 a.m. 

• MDH supports unprecedented amount of overdose prevention work across Minnesota (MDH) 

• Cannabis and hallucinogen use among adults remained at historic highs in 2023 (NIH) 

• NIH launches program to advance research led by Native American communities on substance use and pain (NIDA) 

• FDA issues final rule increasing the minimum age for certain restrictions on tobacco sales (FDA) 

New resources! 

• Guide to hosting a naloxone demonstration (NIDA) 

Data and research 

• Notes from the field: E-cigarette and nicotine pouch use among middle and high school students (MMWR) 

• QuickStats: Age-adjusted drug overdose death rates, by state — United States, 2022  (MMWR) 

• Monitoring the Future Panel Study annual report: National data on substance use among adults ages 19 to 65, 1976-2023 (University of Michigan) 

• Pharmacy naloxone standing order and community opioid fatality rates over time (JAMA Network) 

• Racial and ethnic disparities in take-home methadone use for Medicare beneficiaries with opioid use disorder (JAMA Network) 

• Personality, social factors, brain functioning, familial risk, and trajectories of alcohol misuse in adolescence (JAMA Network) 

• Disparities in medication use for criminal justice system-referred opioid use disorder treatment (JAMA Network) 

• University of Minnesota Neurobiology Research in support of addiction recovery (The Pheonix Spirit) 

Alcohol 

• What is sober curious? (Drug Free) 

• Study identifies alcohol consumption trends across disadvantaged populations, proposes policy solutions to reduce health disparities (Alcohol Research Group) 

• Alcohol consumption increasingly viewed as unhealthy in U.S. (Gallup) 

• Alcohol use disorder medication is safe, effective, and seriously underused (Pew Charitable Trusts) 

Cannabis 

• CBD may actually increase THC's intoxicating effect, new marijuana study finds, contrary to conventional wisdom (Marijuana Moment) 

• St. Paul City Council likely to allow cannabis shops 300 feet from schools (Pioneer Press) 

• Cannabis use tied to head and neck cancer (Science Daily) 

• A decision on a major policy shift on marijuana won't come until after the presidential election (AP News) 

Opioids and prescription drugs 

• How a rural Maine County jail helped prisoners blunt opioid cravings (The New York Times) 

• Hennepin County offering free virtual classes for opioid education and Narcan training (KSTP) 

• An implantable sensor could reverse opioid overdoses (Science Daily) 

• Is there a fentanyl vaccine? Clinical trials to start in Texas in 2025 (Statesman) 

• Narcan reverses opioid overdose. College campuses could use more of it (NPR) 

Commercial tobacco and e-cigarettes 

• Minnesota Attorney General Keith Ellison warns more than 5,000 retailers and distributors about sale of unauthorized tobacco products (Star Tribune) 

• Tobacco buyers under 30 should expect to show ID under new FDA rule (CNN) 

• Tobacco use in the Black American community (Truth Initiative) 

• As teen vaping rates drop, more are turning to this product (USA Today) 

• Stop & Shop will join other major chains and stop selling cigarettes (CNN) 

Other drugs 

• Oregon law rolling back drug decriminalization takes effect, making possession a crime again (PBS News) 

• What to know about delta-8 and other common vape shop drugs (ABC News) 

• New synthetic drug found in Florida up to 20 times stronger than fentanyl, UF expert says (WCTV) 

Psychedelic medicine 

• FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study (AP) 

• Three studies of MDMA treatment retracted by scientific journal (NYT) 

• Lykos to cut 75% of staff after FDA rejection of MDMA-based therapy (BioPharma Dive) 

• Lykos' longtime CEO to step down in latest shakeup after MDMA drug setback (Reuters) 

• US FDA widens probe of MDMA-based drug studies, WSJ reports (Reuters) 

• 48-year-old founded ‘Moms on Mushrooms’ to share the practice of microdosing for mental health (CNBC) 

• MindMed readying Phase III trials for LSD therapy to treat anxiety (MSN)